Last month when a federal jury in Dallas returned a verdict for Gibson, Dunn & Crutcher client Maiden Bioscience, it wasn’t partner Collin Cox sitting at the counsel table. It wasn’t the client either. Cox had told the client there wouldn’t likely be a verdict until after lunch. So when the jury came in after just three hours of deliberations, Cox and the client were both scrambling across town to get to the courthouse as sixth-year associate Matt Scorcio wrote the following notes on his legal pad: “We won. $15 million.”  

The fraudulent transfer verdict the Gibson Dunn team won for the collagen maker landed them a spot as Litigator of the Week Runners-Up back before the holidays. But it accomplished something much more significant for both the firm and the client: It brought home a win while garnering significant stand-up trial experience for Scorcio and his junior associate colleagues Katie Rose Talley and Michael Zarian. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]